Market access is a well-known challenge for innovators seeking to pilot their ideas in the real world. In the mentoring discussions, innovation teams express consistent concerns: How can we implement healthcare innovation in the fastest and most efficient way? How can we ensure it reaches the people that it needs to? How can we achieve buy-in in a target country, in the absence of networks, and with minimal resources?

These questions are all valid and should be addressed.